Nycomed Amersham Imaging has signed a three-year, sole-source agreement to supply group purchasing organization Consorta with its full line of brachytherapy seed products. The agreement, which began on April 1, allows Consorta of Rolling Meadows, IL, to buy brachytherapy products such as OncoSeed, TheraSeed, and RAPID Strand, according to Princeton, NJ-based Nycomed Amersham.
By AuntMinnie.com staff writersJune 1, 2001
Related Reading
Nycomed, HSCA extend contract, May 31, 2001
Nycomed Amersham changes name to Amersham PLC, May 11, 2001
Nycomed gets sole-source TheraSeed deal from Premier, May 9, 2001
MedAssets acquires HSCA, May 7, 2001
Nycomed grows 16%, April 24, 2001
Copyright © 2001 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
